Clincosm LogoSign in Get a demo

COVID-19

Showing NaN - NaN of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Health Behavior, Colorectal Cancer, Influenza Trial in New Orleans (Financial incentive for colorectal cancer screening,

Recruiting
  • Health Behavior
  • +6 more
  • Financial incentive for colorectal cancer screening
  • +2 more
  • New Orleans, Louisiana
    Tulane University School of Medicine
Nov 13, 2023

COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

Not yet recruiting
  • COVID-19
  • XBB.1.5 Vaccine (Booster)
  • XBB.1.5 Vaccine (single dose)
  • Mobile, Alabama
  • +29 more
Aug 4, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Denmark, United States (PF-07304814, Placebo, Remdesivir)

Suspended
  • COVID-19
  • Chula Vista, California
  • +39 more
Mar 22, 2023

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

COVID-19 Trial in Worldwide (ADG20, Placebo)

Terminated
  • COVID-19
  • Birmingham, Alabama
  • +94 more
Nov 22, 2022

Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])

Completed
Has Results
  • Infection Viral
  • +2 more
  • Enoxaparin Prefilled Syringe [Lovenox]
  • Birmingham, Alabama
  • +15 more
Sep 15, 2022

COVID-19 Trial in Worldwide (Remdesivir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +36 more
Aug 18, 2022

COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)

Terminated
Has Results
  • COVID-19
  • SARS-CoV-2
  • Ascorbic Acid
  • +4 more
  • Chicago, Illinois
  • +5 more
Jul 12, 2022

Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID Trial in United States (TNX-102 SL, Placebo SL Tablet)

Recruiting
  • Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
  • +3 more
  • TNX-102 SL
  • Placebo SL Tablet
  • Atlanta, Georgia
  • +4 more
Jul 26, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
  • +10 more
  • Birmingham, Alabama
  • +71 more
Jul 11, 2022

COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +140 more
Jun 7, 2022

COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +71 more
Jun 22, 2022

COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)

Terminated
  • COVID-19
  • Birmingham, Alabama
  • +62 more
Jun 1, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +59 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Interferon beta-1a
  • +2 more
  • Birmingham, Alabama
  • +63 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

Completed
Has Results
  • COVID-19
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +70 more
Mar 9, 2022

COVID-19 Trial in United States (Remdesivir (RDV), Placebo)

Completed
Has Results
  • COVID-19
  • Remdesivir (RDV)
  • Placebo
  • Mesa, Arizona
  • +27 more
Feb 18, 2022